Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩5,350, the stock trades at a trailing P/E ratio of 10.2x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 16% over the past three years. Valuation Update With 7 Day Price Move • Jul 03
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩5,300, the stock trades at a trailing P/E ratio of 10.1x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 3.2% over the past three years. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩5,670, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 17% over the past three years. New Risk • May 27
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩149.2b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₩149.2b market cap, or US$99.5m). New Risk • Apr 07
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩149.4b (US$99.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin). Market cap is less than US$100m (₩149.4b market cap, or US$99.6m). New Risk • Apr 04
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.1% Last year net profit margin: 9.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin). Announcement • Mar 17
Tonymoly Co., Ltd, Annual General Meeting, Mar 31, 2026 Tonymoly Co., Ltd, Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 2557, nambusunhwan-ro, seocho-gu, seoul South Korea Valuation Update With 7 Day Price Move • Mar 03
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩7,250, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 60% over the past three years. Declared Dividend • Mar 02
Dividend reduced to ₩50.00 Dividend of ₩50.00 is 58% lower than last year. Ex-date: 30th March 2026 Payment date: 1st January 1970 Dividend yield will be 0.6%, which is lower than the industry average of 1.2%. Sustainability & Growth Dividend is covered by earnings (15% earnings payout ratio) but not covered by cash flows (225% cash payout ratio). The dividend has increased by an average of 2.6% per year over the past 7 years. However, payments have been volatile during that time. EPS is expected to grow by 70% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Announcement • Feb 28
Tonymoly Co., Ltd announces Annual dividend Tonymoly Co., Ltd announced Annual dividend of KRW 50.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026. Reported Earnings • Nov 16
Third quarter 2025 earnings released: EPS: ₩152 (vs ₩27.00 in 3Q 2024) Third quarter 2025 results: EPS: ₩152 (up from ₩27.00 in 3Q 2024). Revenue: ₩56.3b (up 25% from 3Q 2024). Net income: ₩3.63b (up 463% from 3Q 2024). Profit margin: 6.5% (up from 1.4% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 19
Second quarter 2025 earnings released: EPS: ₩110 (vs ₩162 in 2Q 2024) Second quarter 2025 results: EPS: ₩110 (down from ₩162 in 2Q 2024). Revenue: ₩62.5b (up 33% from 2Q 2024). Net income: ₩2.62b (down 32% from 2Q 2024). Profit margin: 4.2% (down from 8.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth. New Risk • Jul 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to ₩12,540, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 18x in the Personal Products industry in South Korea. Total returns to shareholders of 215% over the past three years. Reported Earnings • May 21
First quarter 2025 earnings released: EPS: ₩87.00 (vs ₩65.00 in 1Q 2024) First quarter 2025 results: EPS: ₩87.00 (up from ₩65.00 in 1Q 2024). Revenue: ₩48.9b (up 17% from 1Q 2024). Net income: ₩2.07b (up 34% from 1Q 2024). Profit margin: 4.2% (up from 3.7% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. New Risk • Mar 31
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.4% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (10% average weekly change). Announcement • Mar 13
Tonymoly Co., Ltd, Annual General Meeting, Mar 28, 2025 Tonymoly Co., Ltd, Annual General Meeting, Mar 28, 2025, at 09:01 Tokyo Standard Time. Location: conference room, 2557, nambusunhwan-ro, seocho-gu, seoul South Korea Announcement • Mar 01
Tonymoly Co., Ltd announces Annual dividend Tonymoly Co. Ltd. announced Annual dividend of KRW 120.0000 per share, ex-date on March 28, 2025 and record date on March 31, 2025. New Risk • Feb 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩7,330, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 64% over the past three years. New Risk • Feb 03
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩143.4b (US$97.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩6,280, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 9x in the Personal Products industry in South Korea. Total returns to shareholders of 30% over the past three years. Reported Earnings • Nov 20
Third quarter 2024 earnings released: EPS: ₩27.00 (vs ₩55.00 in 3Q 2023) Third quarter 2024 results: EPS: ₩27.00 (down from ₩55.00 in 3Q 2023). Revenue: ₩45.0b (up 22% from 3Q 2023). Net income: ₩645.9m (down 51% from 3Q 2023). Profit margin: 1.4% (down from 3.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 111% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. New Risk • Nov 14
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩140.1b (US$99.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩6,240, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Personal Products industry in South Korea. Total loss to shareholders of 1.7% over the past three years. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₩7,990, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 7.4% over the past three years. Buy Or Sell Opportunity • Jul 01
Now 31% undervalued Over the last 90 days, the stock has risen 69% to ₩11,460. The fair value is estimated to be ₩16,651, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 786% in the next 2 years. Buy Or Sell Opportunity • Jun 25
Now 21% undervalued Over the last 90 days, the stock has risen 113% to ₩12,690. The fair value is estimated to be ₩15,976, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 786% in the next 2 years. New Risk • Jun 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin). Buy Or Sell Opportunity • Jun 04
Now 25% undervalued Over the last 90 days, the stock has risen 103% to ₩11,790. The fair value is estimated to be ₩15,701, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 786% in the next 2 years. Valuation Update With 7 Day Price Move • Apr 22
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩8,130, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total returns to shareholders of 11% over the past three years. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to ₩7,260, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 2.6% over the past three years. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩5,950, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total loss to shareholders of 26% over the past three years. Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩5,380, the stock trades at a trailing P/E ratio of 40.3x. Average trailing P/E is 33x in the Personal Products industry in South Korea. Total loss to shareholders of 32% over the past three years. Reported Earnings • Nov 19
Third quarter 2023 earnings released: EPS: ₩55.00 (vs ₩162 in 3Q 2022) Third quarter 2023 results: EPS: ₩55.00 (down from ₩162 in 3Q 2022). Revenue: ₩36.8b (up 29% from 3Q 2022). Net income: ₩1.31b (down 66% from 3Q 2022). Profit margin: 3.6% (down from 14% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment improves as stock rises 36% After last week's 36% share price gain to ₩6,500, the stock trades at a trailing P/E ratio of 39x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total loss to shareholders of 38% over the past three years. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₩4,200, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 27x in the Personal Products industry in South Korea. Total loss to shareholders of 55% over the past three years. New Risk • Jun 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Jun 21
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩5,750, the stock trades at a trailing P/E ratio of 34.5x. Average trailing P/E is 32x in the Personal Products industry in South Korea. Total loss to shareholders of 33% over the past three years. Announcement • Sep 16
An unknown buyer agreed to acquire 50.1% stake in Atogen Co., Ltd. from Tonymoly Co., Ltd (KOSE:A214420) for KRW 7 billion. An unknown buyer agreed to acquire 50.1% stake in Atogen Co., Ltd. from Tonymoly Co., Ltd (KOSE:A214420) for KRW 7 billion on September 15, 2022. As a part of transaction buyer is acquiring 330,800 shares. For the year ended December 31, 2021, Atogen reported Total assets of KRW 3.5 billion and Net income of KRW -3.9 billion. Announcement • Mar 12
Tonymoly Co., Ltd, Annual General Meeting, Mar 26, 2021 Tonymoly Co., Ltd, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time. Reported Earnings • Mar 10
Full year 2020 earnings released: ₩2,165 loss per share (vs ₩311 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: ₩113.5b (down 34% from FY 2019). Net loss: ₩37.9b (loss widened ₩32.4b from FY 2019). Over the last 3 years on average, earnings per share has fallen by 75% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 26
New 90-day low: ₩8,290 The company is down 12% from its price of ₩9,440 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 13% over the same period. Announcement • Feb 05
Tonymoly Co., Ltd to Report Fiscal Year 2020 Results on Feb 09, 2021 Tonymoly Co., Ltd announced that they will report fiscal year 2020 results on Feb 09, 2021 Is New 90 Day High Low • Jan 07
New 90-day low: ₩8,700 The company is down 12% from its price of ₩9,900 on 08 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,281 per share. Is New 90 Day High Low • Dec 22
New 90-day low: ₩8,980 The company is down 7.0% from its price of ₩9,620 on 23 September 2020. The South Korean market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,458 per share. Is New 90 Day High Low • Oct 30
New 90-day low: ₩9,090 The company is down 14% from its price of ₩10,600 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩3,718 per share.